Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by census regions in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Pathophysiological mechanisms linking hyperammonemia to sarcopenia and cerebral changes. by Maria Nadinskaia (22662419)

Subjects:

Effect of <i>slc43a3</i> deletion on physical activity of male and female WT and KO mice. by Aaron L. Sayler (19797446)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the metropolitan and non-metropolitan areas in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Supporting information – data for plots. by Maria Nadinskaia (22662419)

Subjects:

Summary of measured parameters. by Aaron L. Sayler (19797446)

Subjects:

Morphometric analysis of histological slides in sarcopenia modeling by portal vein ligation and pyloric vein ligation. by Maria Nadinskaia (22662419)

Subjects:

Effect of <i>slc43a3</i> deletion on metabolic performance parameters in male and female WT and KO mice. by Aaron L. Sayler (19797446)

Subjects:

Raw data. by Aaron L. Sayler (19797446)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by race in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by age groups in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Liver and spleen mass in sarcopenia-hyperammonemia modelling on Day 30. by Maria Nadinskaia (22662419)

Subjects:

Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

Subjects:

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”

Proteomics and Metabolomics Analyses Reveal a Dynamic Landscape of Coal Workers’ Pneumoconiosis: An Insight into Disease Progression by Yangyang Wei (436909)

“…Proteomics identified proteins that change with the progression of CWP, with significant enrichment in the TGF-β signaling pathway and autoimmune disease pathways. …”